Literature DB >> 12354115

Processing, stability, and kinetic parameters of C5a peptidase from Streptococcus pyogenes.

Elizabeth T Anderson1, Michael G Wetherell, Laurie A Winter, Stephen B Olmsted, Patrick P Cleary, Yury V Matsuka.   

Abstract

A recombinant streptococcal C5a peptidase was expressed in Escherichia coli and its catalytic properties and thermal stability were subjected to examination. It was shown that the NH2-terminal region of C5a peptidase (Asn32-Asp79/Lys90) forms the pro-sequence segment. Upon maturation the propeptide is hydrolyzed either via an autocatalytic intramolecular cleavage or by exogenous protease streptopain. At pH 7.4 the enzyme exhibited maximum activity in the narrow range of temperatures between 40 and 43 degrees C. The process of heat denaturation of C5a peptidase investigated by fluorescence and circular dichroism spectroscopy revealed that the protein undergoes biphasic unfolding transition with Tm of 50 and 70 degrees C suggesting melting of different parts of the molecule with different stability. Unfolding of the less stable structures was accompanied by the loss of proteolytic activity. Using synthetic peptides corresponding to the COOH-terminus of human complement C5a we demonstrated that in vitro peptidase catalyzes hydrolysis of two His67-Lys68 and Ala58-Ser59 peptide bonds. The high catalytic efficiency obtained for the SQLRANISHKDMQLGR extended peptide compared to the poor hydrolysis of its derivative Ac-SQLRANISH-pNA that lacks residues at P2'-P7' positions, suggest the importance of C5a peptidase interactions with the P' side of the substrate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354115     DOI: 10.1046/j.1432-1033.2002.03183.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Structure of the streptococcal cell wall C5a peptidase.

Authors:  C Kent Brown; Zu-Yi Gu; Yury V Matsuka; Sai S Purushothaman; Laurie A Winter; P Patrick Cleary; Stephen B Olmsted; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

2.  Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.

Authors:  Hae-Sun Park; P Patrick Cleary
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  High-affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity.

Authors:  Glen S Tamura; James R Hull; Michael D Oberg; David G Castner
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease.

Authors:  Malgorzata Teçza; Todd F Kagawa; Monica Jain; Jakki C Cooney
Journal:  Comput Struct Biotechnol J       Date:  2021-04-17       Impact factor: 7.271

6.  Immunogenicity Assessment of Different Segments and Domains of Group a Streptococcal C5a Peptidase and Their Application Potential as Carrier Protein for Glycoconjugate Vaccine Development.

Authors:  Guirong Wang; Jielin Zhao; Yisheng Zhao; Subo Wang; Shaojie Feng; Guofeng Gu
Journal:  Vaccines (Basel)       Date:  2021-02-09

Review 7.  The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System.

Authors:  Sophie McKenna; Kristin Krohn Huse; Sean Giblin; Max Pearson; Mohammed Said Majid Al Shibar; Shiranee Sriskandan; Stephen Matthews; James Edward Pease
Journal:  J Innate Immun       Date:  2021-10-14       Impact factor: 7.111

8.  Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG.

Authors:  Mark Reglinski; Nicola N Lynskey; Yoon Jung Choi; Robert J Edwards; Shiranee Sriskandan
Journal:  J Infect       Date:  2016-02-12       Impact factor: 6.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.